Humacyte, Inc. (HUMAW)

USD 1.28

(-7.24%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019
Revenue - 1.56 Million 1.26 Million 1.49 Million 6.18 Million
Cost of Revenue 76.55 Million 8.25 Million 49 Thousand 8.43 Million 75.6 Million
Gross Profit -76.55 Million -6.69 Million 1.21 Million -6.94 Million -69.41 Million
Operating Expenses 23.49 Million 84.57 Million 81.2 Million 64.6 Million 16.27 Million
Selling, General and Administrative Expenses 20.39 Million 22.88 Million 21.13 Million 12.01 Million 16.27 Million
Research and Development Expenses 76.55 Million 63.26 Million 61.34 Million 54.07 Million 75.6 Million
Other Expenses -73.44 Million -1.56 Million -1.26 Million -1.49 Million -
Cost and Expenses 100.04 Million 84.57 Million 81.2 Million 64.6 Million 91.87 Million
Operating Income -100.04 Million -84.57 Million -81.2 Million -64.6 Million -85.69 Million
Interest Expense 1.13 Million 6.2 Million 4.34 Million 2.2 Million 2.29 Million
Income Tax Expense - -76.18 Million -64.01 Million 2.2 Million -
Earnings before Tax -110.77 Million -11.96 Million -26.47 Million -66.52 Million -85.42 Million
Net Income -110.77 Million 64.21 Million 37.53 Million -68.72 Million -85.42 Million
Earnings Per Share Basic -1.07 0.62 0.94 -5.52 -4.25
Earnings Per Share Diluted -1.07 0.62 0.94 -5.52 -4.25
Weighted Average Shares Outstanding 103.42 Million 103.05 Million 39.97 Million 12.44 Million 20.12 Million
Weighted Average Shares Outstanding (Diluted) 103.42 Million 103.05 Million 39.97 Million 12.44 Million 20.12 Million
Gross Margin - -4.27 0.96 -4.66 -11.22
EBIT Margin - -102.46 -108.46 -37.54 -12.76
Profit Margin - 41.03 29.72 -46.09 -13.81
EBITDA -96.45 Million 2.49 Million -72.96 Million -56.24 Million -78.94 Million
Earnings Before Tax Margin - -54.04 -64.30 -43.33 -13.85

Income Statement Charts